Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of DKK 163.29 billion. The enterprise value is 187.14 billion.

Market Cap	163.29B
Enterprise Value	187.14B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Coloplast has 225.17 million shares outstanding. The number of shares has increased by 2.97% in one year.

Current Share Class	n/a
Shares Outstanding	225.17M
Shares Change (YoY)	+2.97%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	5.66%
Owned by Institutions (%)	24.30%
Float	141.39M

Valuation Ratios

The trailing PE ratio is 33.43 and the forward PE ratio is 28.60. Coloplast's PEG ratio is 2.41.

PE Ratio	33.43
Forward PE	28.60
PS Ratio	5.95
PB Ratio	10.56
P/TBV Ratio	n/a
P/FCF Ratio	91.89
P/OCF Ratio	54.70
PEG Ratio	2.41

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.79, with an EV/FCF ratio of 105.31.

EV / Earnings	38.32
EV / Sales	6.82
EV / EBITDA	21.79
EV / EBIT	25.29
EV / FCF	105.31

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.60.

Current Ratio	0.81
Quick Ratio	0.49
Debt / Equity	1.60
Debt / EBITDA	2.88
Debt / FCF	13.93
Interest Coverage	8.97

Financial Efficiency

Return on equity (ROE) is 31.94% and return on invested capital (ROIC) is 12.02%.

Return on Equity (ROE)	31.94%
Return on Assets (ROA)	9.54%
Return on Invested Capital (ROIC)	12.02%
Return on Capital Employed (ROCE)	20.80%
Revenue Per Employee	1.65M
Profits Per Employee	293,721
Employee Count	16,639
Asset Turnover	0.57
Inventory Turnover	2.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.34% in the last 52 weeks. The beta is 0.60, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-21.34%
50-Day Moving Average	739.50
200-Day Moving Average	837.44
Relative Strength Index (RSI)	54.50
Average Volume (20 Days)	236,853

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of DKK 27.45 billion and earned 4.88 billion in profits. Earnings per share was 21.69.

Revenue	27.45B
Gross Profit	18.52B
Operating Income	7.40B
Pretax Income	6.61B
Net Income	4.88B
EBITDA	8.30B
EBIT	7.40B
Earnings Per Share (EPS)	21.69

Full Income Statement

Balance Sheet

The company has 906.00 million in cash and 24.76 billion in debt, giving a net cash position of -23.85 billion or -105.93 per share.

Cash & Cash Equivalents	906.00M
Total Debt	24.76B
Net Cash	-23.85B
Net Cash Per Share	-105.93
Equity (Book Value)	15.46B
Book Value Per Share	68.66
Working Capital	-2.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.99 billion and capital expenditures -1.21 billion, giving a free cash flow of 1.78 billion.

Operating Cash Flow	2.99B
Capital Expenditures	-1.21B
Free Cash Flow	1.78B
FCF Per Share	7.89

Full Cash Flow Statement

Margins

Gross margin is 67.45%, with operating and profit margins of 26.95% and 17.79%.

Gross Margin	67.45%
Operating Margin	26.95%
Pretax Margin	24.08%
Profit Margin	17.79%
EBITDA Margin	30.24%
EBIT Margin	26.95%
FCF Margin	6.47%

Dividends & Yields

This stock pays an annual dividend of 22.00, which amounts to a dividend yield of 3.03%.

Dividend Per Share	22.00
Dividend Yield	3.03%
Dividend Growth (YoY)	4.76%
Years of Dividend Growth	12
Payout Ratio	101.47%
Buyback Yield	-2.97%
Shareholder Yield	0.07%
Earnings Yield	2.99%
FCF Yield	1.09%

Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 5.07.

Altman Z-Score	5.07
Piotroski F-Score	n/a